Expect to Dispense Tocilizumab for COVID-19 Under an EUA

You'll likely hear more about using tocilizumab or other meds along with steroids to treat COVID-19 in hospitalized patients.

It's partly because of results from recent studies looking at IL-6 inhibitors (tocilizumab, etc)...or Janus kinase (JAK) inhibitors (baricitinib, tofacitinib, etc)...given with steroids (dexamethasone, etc).

If an add-on is used, expect to usually see orders for tocilizumab (Actemra). It has more evidence for mortality reduction in COVID-19 INpatients.

Get unlimited access through an Enterprise license

Hospital Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals